---
document_datetime: 2023-09-21 21:53:18
document_pages: 13
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps/inomax-epar-procedural-steps-taken-authorisation_en.pdf
document_name: inomax-epar-procedural-steps-taken-authorisation_en.pdf
version: success
processing_time: 22.1007222
conversion_datetime: 2025-12-25 01:59:18.011866
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## INOmax

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued² / amended on   | Product Information affected3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|-----------|
| N/0066               | Minor change in labelling or package leaflet not connected with the SPC(Art.61.3 Notification)                                                 | 18/04/2023                          |                                            | PL                              |           |
| IA/0065              | B.IIl.1.a.2-Submission of a new/updated or deletion ofPh.Eur.Certificate ofSuitability to the relevant Ph. Eur. Monograph -Updated certificate | 22/11/2022                          | n/a                                        |                                 |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                    | from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                       |            |            |                        |                                |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------|
| PSUSA/2172/ 202112 | PeriodicSafetyUpdateEUSingle assessment-nitric oxide                                                                                                                                                                                                                                                                                                                                                                                                                        | 01/09/2022 | n/a        |                        | PRACRecommendation-maintenance |
| IB/0063/G          | This was an application for a group of variations. B.II.b.1.e-Replacement or addition of a manufacturing sitefortheFp-Sitewhere any manufacturing operation(s)takeplace,exceptbatch- release,batchcontrol,primary andsecondary packaging, for non-sterile medicinal products B.II.b.1.b-Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.c.2-Changetoimporter,batchrelease arrangements and quality control testing of the FP - | 05/08/2021 | n/a        |                        |                                |
| IA/0062            | B.III.1.a.2-Submission of a new/updated or deletion ofPh.Eur.Certificateof Suitability to the relevantPh.Eur.Monograph-Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                            | 28/05/2021 | n/a        |                        |                                |
| N/0061             | Minorchangeinlabellingorpackageleafletnot connected with the SPC(Art.61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                     | 20/10/2020 | 19/02/2021 | PL                     |                                |
| IAIN/0060          | A.1-Administrativechange-Changeinthename and/oraddressoftheMAH                                                                                                                                                                                                                                                                                                                                                                                                              | 08/05/2020 | 19/02/2021 | SmPC, Labelling and PL |                                |

<div style=\"page-break-after: always\"></div>

| IB/0058            | C.I.z-Changes(Safety/Efficacy)of Human and Veterinary Medicinal Products-Othervariation                                                                                                                                                                                                                                                                                                                                                                             | 26/02/2020   | 19/02/2021   | SmPC,  Labelling and PL   |                                |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------------------|--------------------------------|
| IA/0059            | A.7-Administrativechange-Deletionof manufacturingsites                                                                                                                                                                                                                                                                                                                                                                                                              | 14/01/2020   | n/a          |                           |                                |
| IB/0057            | B.II.e.1.z - Change in immediate packaging of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                | 22/11/2019   | n/a          |                           |                                |
| PSUSA/2172/ 201812 | PeriodicSafetyUpdateEUSingleassessment-nitric oxide                                                                                                                                                                                                                                                                                                                                                                                                                 | 11/07/2019   | n/a          |                           | PRACRecommendation-maintenance |
| IA/0055            | B.I1.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change inthemanufacturingprocess                                                                                                                                                                                                                                                                                                                                   | 26/10/2018   | n/a          |                           |                                |
| 11/0051            | B.IV.1.c-Change of a measuring or administration device-Additionorreplacementofadevicewhichis anintegratedpart of theprimarypackaging                                                                                                                                                                                                                                                                                                                               | 22/03/2018   | 11/03/2019   | SmPC, Labelling and PL    |                                |
| IB/0054/G          | This was an applicationfor a group of variations. B.II.b.1.e-Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release,batch control,primary andsecondary packaging,fornon-sterile medicinal products B.III.1.a.3-Submission of a new/updated or deletionofPh.Eur.CertificateofSuitabilityto the relevantPh.Eur.Monograph-Newcertificatefroma newmanufacturer(replacementoraddition) | 15/02/2018   | n/a          |                           |                                |

<div style=\"page-break-after: always\"></div>

|                    | B.II.b.3.z-Changein themanufacturingprocessof the finished orintermediateproduct-Othervariation                                                                                                                 |            |            |                        |                                |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------|
| PSUSA/2172/ 201706 | Periodic Safety Update EU Single assessment - nitric oxide                                                                                                                                                      | 08/02/2018 | n/a        |                        | PRACRecommendation-maintenance |
| IA/0053            | B.II.e.4.a-Changeinshapeordimensionsofthe container or closure(immediate packaging)-Non- sterilemedicinalproducts                                                                                               | 04/10/2017 | n/a        |                        |                                |
| IB/0049            | B.II.c.2.d-Change in test procedure for an excipient - Other changes to a test procedure (including replacement oraddition)                                                                                     | 19/05/2017 | n/a        |                        |                                |
| IA/0050            | A.4-Administrative change-Change in the name and/oraddressofamanufactureroranASMFholder orsupplieroftheAS，startingmaterial,reagentor intermediateused inthemanufactureof theASor manufacturerofanovel excipient | 24/03/2017 | n/a        |                        |                                |
| PSUSA/2172/ 201606 | Periodic Safety Update EU Single assessment - nitric oxide                                                                                                                                                      | 09/02/2017 | n/a        |                        | PRACRecommendation-maintenance |
| IB/0047            | C.I.z - Changes (Safety/Efficacy) of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                                       | 19/08/2016 | 16/02/2017 | SmPC, Labelling and PL |                                |
| IAIN/0046          | A.5.a-Administrative change-Change in the name and/oraddressofamanufacturer/importer responsibleforbatchrelease                                                                                                 | 10/03/2016 | 16/02/2017 | Annex II and PL        |                                |

<div style=\"page-break-after: always\"></div>

| PSUSA/2172/ 201506   | PeriodicSafetyUpdateEUSingle assessment-nitric pixo                                                                                                                                                                                                                                                                                                                        | 14/01/2016   | n/a        |                       | PRACRecommendation-maintenance   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------------|----------------------------------|
| N/0045               | Minor change in labelling or package leaflet not connectedwiththeSPC(Art.61.3Notification)                                                                                                                                                                                                                                                                                 | 27/11/2015   | 16/02/2017 | PL                    |                                  |
| IA/0044              | B.II.c.4.a-Change in synthesis or recovery of a non- pharmacopoeial or novel excipient - Minor change                                                                                                                                                                                                                                                                      | 12/11/2015   | n/a        |                       |                                  |
| PSUSA/2172/ 201412   | PeriodicSafetyUpdateEUSingle assessment-nitric pixo                                                                                                                                                                                                                                                                                                                        | 10/09/2015   | n/a        |                       | PRACRecommendation-maintenance   |
| IAIN/0042            | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (includingcontactdetails)and/or changesinthe PSMFlocation                                                                                                                                                                                                                  | 16/07/2015   | n/a        |                       |                                  |
| PSUSA/2172/ 201406   | PeriodicSafetyUpdateEUSingle assessment-nitric oxide                                                                                                                                                                                                                                                                                                                       | 12/02/2015   | n/a        |                       | PRACRecommendation-maintenance   |
| 11/0039              | SubmissionofanupdatedRMPforINOmaxand updateofAnnexIItonolongerrequirethatthe educationalmaterialforHealthcareProfessionals shouldbe'apocketsizeguide' In addition, the MAH took the opportunity to update thelistoflocalrepresentativesinthePackage Leaflet. Furthermore,theMAH mademinoreditorial corrections andbrought thePIin line withthelatest QRD template version. | 25/09/2014   | 18/09/2015 | SmPC, Annex II and PL |                                  |

<div style=\"page-break-after: always\"></div>

|                    | C.I.11.b - Introduction of, or change(s) to, the obligations andconditions of amarketing authorisation,including the RMp-Implementation of change(s)whichrequire tobefurthersubstantiated bynewadditionaldatatobesubmittedbytheMAH where significant assessment is required                                                                                                                                                                                                                       |            |            |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/2172/ 201312 | PeriodicSafetyUpdateEUSingle assessment-nitric pixo                                                                                                                                                                                                                                                                                                                                                                                                                                               | 10/07/2014 | n/a        |             | PRACRecommendation-maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| PSUSA/2172/ 201306 | PeriodicSafetyUpdateEUSingle assessment-nitric pixo                                                                                                                                                                                                                                                                                                                                                                                                                                               | 09/01/2014 | n/a        |             | PRACRecommendation-maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| I1/0036            | Update ofsection5.3oftheSmPC\"Preclinical safety data\"toremovetheriskofuterine adenocarcinomas further to thereviewof theresultsofthetoxicity and carcinogenicity studyinrats(studyN0055243), previously assessed by the CHMP. TheMAH alsotooktheopportunity toupdatethe contactinformationofseverallocalrepresentatives in thePackageLeaflet,including theCroatianlocal representative. C.I.4-Change(s)intheSPC,LabellingorPL due to new quality, preclinical, clinical or pharmacovigilance data | 21/11/2013 | 16/01/2014 | SmPC and PL | A further review of a 2-year carcinogenicity study in rats performedin2006,aswellasthereviewofhistoricaldata acrossanumberofpublishedcarcinogenicitystudies and theNTPpublically availablehistorical control data,support theconclusion thatnone of theuterinelesionsobserved were considered toberelated toNOexposure.Themost likely explanation is that it is a spontaneous lesion. Intermsofbiologicalplausibility,thereisnoclear mechanism thatwouldsuggestaroleof NOinepithelial uterineneoplasia,withbiologicaleffectsmoreclearly related to smoothmuscle. Therefore,section5.3oftheSmPCisbeingupdatedto reflectthatin the2-yearcarcinogenicitystudyno evidence ofa carcinogeniceffectwas apparent,atinhalation exposures up to the recommended dose (20 ppm), in rats for 20 h/day for up to two years, and that higher exposures have not been investigated. |

<div style=\"page-break-after: always\"></div>

| IB/0035   | B.II.b.4.a-Changeinthebatchsize(includingbatch sizeranges)of the finished product-Upto10-fold comparedtothecurrentlyapprovedbatchsize                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 17/05/2013   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0034    | Minorchangeinlabellingorpackageleafletnot connectedwiththeSPC(Art.61.3Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 16/04/2013   | 16/01/2014 | PL                               | UpdateoftheSlovakianlocalrepresentative'saddressin thePackageLeaflet.TheMAH also tookthe opportunity to addpreviouslymissing addressesinthelist of local representativesin theBulgarianPackageLeaflet.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| I1/0030   | Updateoftheadverseeventstableinsection4.8of theSmPCfollowing areviewof thesafety data derivedfrom theCNRGI pivotal study in term/near- termneonatesandpost-marketingsafety surveillance,asrequestedbythe CHMP.Update of therelevantsectionsof thepackageleaflet accordingly. Moreover astatementwas addedinsection6.6 `Specialprecautionsfordisposal andotherhandling' oftheSmPCregarding thedisposalofINOmax. Additionally,theproductinformationhasbeen updatedwithsome minor linguistic amendments and inaccordancewiththelatestQRDtemplate. C.I.3.b-Implementation of change(s)requested following the assessment of anUSR,classlabelling,a PSUR,RMP,FUM/SO,datasubmittedunderArticle 45/46,oramendmentstoreflectaCoreSPC- Change(s)withnewadditional data submitted by the MAH | 17/01/2013   | 16/01/2014 | SmPC, Annex II, Labelling and PL | Furthertothereviewofthesafetydataderivedfromthe CNRGIpivotalstudyinterm/neartermneonatesandpost- marketingsurveillanceandpost-marketingsafety surveillance,thetabulatedlistofadversereactionshas beenupdatedtomoreaccuratelyreflectadversedrug reactions,adjustfrequenciestoalsoconsidertheincreased numberofexposedpatients(from300,000to482,585 subjects) and comply with the latest relevant guidelines and templates. ‘Hypokalemia'，and'hyperbilirubinemia'havebeenremoved from section 4.8 of the SmPC as these are not considered tobeassociatedwiththeuseofINOmaxandbradycardia' (following abrupt discontinuation of therapy),'hypoxia', `chestdiscomfort'，`dizziness'，'dry throat'，`dyspnea'and headache'havebeen added insection4.8. Moreover astatementwas addedinsection6.6of the SmPCregarding theprecautionsfordisposal ofINOmax. |
| IAIN/0033 | A.1-Administrative change-Change in the name and/oraddressoftheMAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 21/12/2012   | 16/01/2014 | SmPC, Labelling and              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                  |            |            | PL   |              |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|--------------|
| IB/0032/G | This was an application for a group of variations. B.II.b.4.z-Change in the batch size (including batch sizeranges)of thefinishedproduct-Othervariation B.II.b.3.z-Change in the manufacturing process of the finished product - Other variation | 29/11/2012 | n/a        |      |              |
|           | B.I.a.3.a-Change inbatchsize(includingbatchsize ranges)ofASorintermediate-Up to10-fold increasecompared tothecurrentlyapprovedbatch                                                                                                              | 24/08/2012 | n/a        |      | IA/0031 size |
| N/0029    | Inclusion of thelistof localrepresentatives at the endof thePackageLeaflet. Minorchangeinlabellingorpackageleafletnot connectedwiththeSPC(Art.61.3Notification)                                                                                  | 07/06/2012 | 29/10/2012 | PL   |              |
|           | C.I.9.d-Changestoanexistingpharmacovigilance system as described in the DDPS - Change in the safety database                                                                                                                                     | 11/05/2012 | n/a        |      | IAIN/0028    |
| IB/0027   | B.II.f.1.b.1-Stability of FP-Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                            | 10/05/2012 | 29/10/2012 | SmPC |              |
|           | This was an application for a group of variations. B.1.b.2.a-Changein test procedure forAS or startingmaterial/reagent/intermediate-Minor                                                                                                        | 10/05/2012 | n/a        |      | IB/0026/G    |

<div style=\"page-break-after: always\"></div>

|         | changesto anapprovedtestprocedure B.I.b.2.e -Change in test procedure forAS or startingmaterial/reagent/intermediate-Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                                                                                         |            |            |                                   |                                                                                        |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------------------|----------------------------------------------------------------------------------------|
| IB/0025 | B.II.b.5.c -Change to in-process tests orlimits applied during the manufacture of the finished product - Deletion of a non-significant in-process test                                                                                                                                                                                                                                                                                                                                                                                                                            | 06/03/2012 | n/a        |                                   |                                                                                        |
| X/0021  | Annex I_2.(c) Change or addition of a new strength/potency                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 20/01/2011 | 18/03/2011 | SmPC, Annex II, Labelling  and PL |                                                                                        |
| 11/0019 | Extensionof thetherapeuticindicationtoincludethe treatmentofpulmonaryhypertensionperi-andpost heart surgery in children and adults in 4.1 of the SmPC.Posologyinstructionsfor thisnewindication includingattemptsforweaning/toweanfrom INOmaxhavebeenproposedinsection4.2. Furthermore,changesto theSmPChavebeen proposed for section 4.4,4.8and5.1.ThePIL has beenmodified accordingly.Moreover,AnnexIIwas tobeupdated and anAnnex127ahasbeen introduced. C.1.6.a - Change(s) to therapeutic indication(s) - Additionof anewtherapeuticindication or modificationofanapprovedone | 20/01/2011 | 17/03/2011 | SmPC, Annex II, Labelling and PL  | PleaserefertotheScientificDiscussion \"INOmax/H/C/000337/I1/0019\"forfurtherinformation. |

<div style=\"page-break-after: always\"></div>

| II/0022   | Update of sections 4.2,4.4 and 5.1 of the SmPC to includeefficacy andsafetydatafromstudyINOT27, asrequestedby the CHMP. C.1.3.b - Implementation of change(s) requested following theassessmentofanUSR,classlabelling,a PSUR,RMP,FUM/SO,datasubmittedunderArticle 45/46,or amendments toreflect aCoreSPC - Change(s)with new additional data submitted by the MAH   | 16/12/2010   | 21/01/2011   | SmPC            | Thesafetyand efficacy ofINOmaxinpremature infants less than 34 weeks of gestation has not yet been established. In theINOT27 trial,795preterm infants(GA<29weeks) withhypoxicrespiratoryfailurewererandomisedtoreceive either INOmax (n=395) in a dose of 5 ppm or nitrogen (placebo n=400),beginningwithin the first 24hours of life and treated for at least 7 days, up to 21 days. The primary outcome,ofthecombinedefficacyendpointsofdeathor BPDat36weeksGA,wasnotsignificantlydifferent betweengroups.Theoveralloccurrenceofintraventricular haemorrhagewas114(28.9%)amongtheiNOtreatedas compared to91(22.9%)among the control neonates.The overallnumberofdeath atweek36wasslightlyhigherin the iNOgroup;53/395(13.4%)ascomparedtocontrol 42/397(10.6%).TheIN0T25 trial,studying the effects of iNO in hypoxic preterm neonates, did not show improvement in alive withoutBDP.Nodifference in the incidenceofIVHordeathwashoweverobservedinthis study.TheBALLR1 study,alsoevaluating theeffectsofiNO inpretermneonates，butinitiatingiNOat7daysandina dose of 20 ppm, found a significant increase in neonates alive withoutBPD at gestational week36,121(45%vs95 (35.4%)p<0.028.Nosignsofanyincreaseadverseeffects   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0023   | A.5.a-Administrative change -Change in the name and/oraddressof amanufacturerresponsiblefor batchrelease                                                                                                                                                                                                                                                            | 15/10/2010   | n/a          | Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

<div style=\"page-break-after: always\"></div>

| IA/0020   | A.5.a - Administrative change - Change in the name and/oraddress of amanufacturerresponsiblefor batch release                                                                     | 01/06/2010   | n/a        | Annex II and PL   |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0017   | Updateofsection5.3oftheSPCfollowingthe finalisation of the carcinogenicity study N005243 and theCHMPassessmentofFollowUpMeasureFU2 013.1. UpdateofSummaryofProductCharacteristics | 24/09/2009   | 29/10/2009 | SmPC              | The SPC has been updated with new statements which are more conciseinorderto avoidrepetition andmaintainthe non clinical information required by the prescriber. The findings from 2 year carcinogenicity study study showing a low incidence of uterine adenocarcinoma in rats following dailyexposuretotherecommendedhumandosehavenow been included.Thewording of the carcinogenicity and mutagenicity information is modified for clarity. |
| I1/0014   | Change to thenitric oxide specification:changes in the selection oftests,in thelimits,in the analytical methods and in thenumbering of the analytical methods Quality changes     | 24/09/2009   | 29/09/2009 |                   |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| IB/0016   | IB_33_Minor changein themanufactureof the finished product                                                                                                                        | 03/07/2009   | n/a        |                   |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| IB/0013   | IB_12_b_02_Change in spec.of active subst./agent inmanuf.ofactive subst.-testparameter                                                                                            | 15/05/2009   | n/a        |                   |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| IA/0015   | IA_12_a_Change in spec. of active subst./agent used in manuf.of active subst.-tightening of spec.                                                                                 | 06/05/2009   | n/a        |                   |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| IB/0011   | IB_33_Minor changein themanufactureof the finished product                                                                                                                        | 26/02/2009   | n/a        |                   |                                                                                                                                                                                                                                                                                                                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

| N/0010   | The Marketing Authorisation Holder (MAH) applied to updatesection6of thePackage Leaflet(PL)to removethecontacttelephone andfaxnumbersof themanufacturer. Additionally, a correction was made in section 6 of thePLfor theLatvian translation. Minor changeinlabellingorpackageleafletnot connected with theSPC(Art.61.3 Notification)                                                                                                                                  | 13/10/2006   | n/a        | PL                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0008   | Renewal of themarketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                 | 01/06/2006   | 28/07/2006 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| IA/0009  | IA_05_Change in thename and/or address of a manufacturerofthefinishedproduct                                                                                                                                                                                                                                                                                                                                                                                           | 03/05/2006   | n/a        | Annex II and PL        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| IA/0007  | IA_32_a_Change inbatchsize of thefinishedproduct - up to 10-fold                                                                                                                                                                                                                                                                                                                                                                                                       | 20/08/2004   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| I1/0006  | Thisvariationconcerns anupdateof section4.5of theSummaryofProductCharacteristics(SPC)to includeprilocaine as anexampleof a drug with knowntendencytoincreasemethaemoglobin，as requestedbyCHMPfollowingthe assessmentofthe secondPeriodicSafetyUpdateReport.In addition, section4.8of theSPCisupdatedtoreflectdatafrom post-marketingexperience.Corresponding changes havebeen included in thePackageLeaflet. UpdateofSummaryofProductCharacteristicsand PackageLeaflet | 03/06/2004   | 02/08/2004 | SmPC and PL            | Thisvariationconcernsanupdateofsection4.5of the Summary ofProduct Characteristics(SPC)toinclude prilocaine asanexampleofadrugwithknowntendency to increasemethaemoglobin，asrequestedbytheCHMP followingthe assessmentofthesecondPeriodicSafety UpdateReport(PSUR).Inadditionthefollowingadverse reactionswhichhadbeenreported aspartofthepost- marketingsurveillancewere addedtosection4.8ofthe SPC:headachesassociatedwithenvironmentalexposure, hypotension associated with acute withdrawal of the drug, hypoxaemia associated with acute withdrawal of the drug, |

<div style=\"page-break-after: always\"></div>

|        |                                                                                     |            |            |                         | and dose errors associated with the delivery system.            |
|--------|-------------------------------------------------------------------------------------|------------|------------|-------------------------|-----------------------------------------------------------------|
| T/0005 | TransferofMarketingAuthorisation                                                    | 08/10/2003 | 01/12/2003 | SmPC,  Labelling and PL | MarketingAuthorisationtransferredfromAGAABtoINO TherapeuticsAB. |
| 1/0004 | 01_Changeinthenameofamanufacturerof the medicinal product                           | 20/08/2003 | 02/10/2003 | Annex II and PL         |                                                                 |
| 1/0003 | 30_Changeinpacksizefor amedicinalproduct                                            | 23/09/2002 | 22/10/2002 | SmPC, Labelling and PL  |                                                                 |
| 1/0001 | 31_Change in container shape                                                        | 21/11/2001 | 27/02/2002 |                         |                                                                 |
| N/0002 | Minorchangeinlabellingorpackageleafletnot connectedwiththeSPC(Art.61.3Notification) | 31/01/2002 | 02/04/2002 | PL                      |                                                                 |